Chang Park

Discovery and Design of Novel HSP90 Inhibitors Using Multiple Fragment‐based Design Strategies

Jean M. Severin, P. Hajduk, J. R. Huth, 2007, Chemical biology & drug design.

Correction to Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity.

Scott A. Erickson, C. Tse, A. Petros, 2015, Journal of medicinal chemistry.

Lack of stereospecificity in the binding of the P2 amino acid of ritonavir to HIV protease

A. D. Rodrigues, S. Muchmore, A. Molla, 1997 .

Kinase Drug Discovery by Affinity Selection/Mass Spectrometry (ASMS): Application to DNA Damage Checkpoint Kinase Chk1

Hua Tang, Mark E Schurdak, Michael Coen, 2006, Journal of biomolecular screening.

Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains.

V. Stoll, S. Vasavanonda, D. Norbeck, 2005, Bioorganic & medicinal chemistry letters.

Structure-Based Design of A-1293102, a Potent and Selective BCL-XL Inhibitor.

Chaohong Sun, Z. Tao, P. Kovar, 2021, ACS medicinal chemistry letters.

X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 protease.

V. Stoll, R. Simmer, D. Norbeck, 2002, Bioorganic & medicinal chemistry.